Research.Patient.info

Relapsed and/or Refractory B-cell Lymphoma research hub

1 indexed studies · 1 currently recruiting

recruitingPHASE1, PHASE2
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
This study looks at new treatments, KITE-363 and KITE-753, for B-cell lymphoma that has come back or not responded to previous treatments. It aims to see how safe and effective these new drugs are for patients.
United States · Australia · Canada